Hong Kong biomedical stocks continued strong outbreak again, clover biological (02197.HK) rose nearly 24%, pioneering pharmaceutical (09939.HK) rose more than 20%, Lepu biological (02157.HK), heart medical (02160.HK) rose more than 10%, Kolombotai biological (06990.HK) rose more than 8.5%.
Most of the Hong Kong pharmaceutical stocks strengthened, Cinda biological (01801.HK) rose nearly 15%, the development of pharmaceutical (09939.HK) rose more than 7%, Shiyao Group (01093.HK) rose more than 5%, China Biopharmaceutical (01177.HK) rose more than 4%.
港股药品股多数走强,信达生物(01801.HK)涨近15%,开拓药业(09939.HK)涨超7%,石药集团(01093.HK)涨超5%,中国生物制药(01177.HK)涨超4%。